Omicinsight Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Buyout/​LBO
  • (In Progress)

  • Investors
  • 2

Omicinsight General Information

Description

Developer of a single-cell analysis platform designed to deliver molecular insights for biomedical research. The company's platform offers single-molecule sensitivity, resolution imaging, customizable analysis pipelines, and AI-driven data interpretation, enabling researchers, laboratories, and biotechnology organizations to uncover precise cellular insights and accelerate discoveries in medicine and life sciences.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2255 Martin Avenue
  • Suite D
  • Santa Clara, CA 95050
  • United States
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • 2255 Martin Avenue
  • Suite D
  • Santa Clara, CA 95050
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Omicinsight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Buyout/LBO 18-Nov-2024 In Progress Generating Revenue
2. Early Stage VC 04-Feb-2026 Completed Generating Revenue
1. Early Stage VC 01-Jan-2024 $54M $54M Completed Generating Revenue
To view Omicinsight’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Omicinsight Patents

Omicinsight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260318834-A1 Digital pathology-based biomarker detection using fluorescent image analysis of chromogenic ihc stains Pending 13-Apr-2025
WO-2026221981-A1 Digital pathology-based biomarker detection using fluorescent image analysis of chromogenic ihc stains Pending 13-Apr-2025
US-11366303-B2 Method for detecting particles using structured illumination Inactive 30-Jan-2018
US-11841495-B2 Method for detecting particles using structured illumination Active 30-Jan-2018
US-20190235222-A1 Method for detecting particles using structured illumination Active 30-Jan-2018 G02B21/367
To view Omicinsight’s complete patent history, request access »

Omicinsight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Omicinsight Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lifecore Partners Venture Capital Minority
Lotte Holdings (Japan) Corporation Minority
To view Omicinsight’s complete investors history, request access »

Omicinsight FAQs

  • When was Omicinsight founded?

    Omicinsight was founded in 2024.

  • Where is Omicinsight headquartered?

    Omicinsight is headquartered in Santa Clara, CA.

  • What is the size of Omicinsight?

    Omicinsight has 9 total employees.

  • What industry is Omicinsight in?

    Omicinsight’s primary industry is Biotechnology.

  • Is Omicinsight a private or public company?

    Omicinsight is a Private company.

  • What is Omicinsight’s current revenue?

    The current revenue for Omicinsight is .

  • How much funding has Omicinsight raised over time?

    Omicinsight has raised $54M.

  • Who are Omicinsight’s investors?

    Lifecore Partners and Lotte Holdings (Japan) have invested in Omicinsight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process